vTv Therapeutics (VTVT) Other Non-Current Liabilities (2014 - 2022)

vTv Therapeutics has disclosed Other Non-Current Liabilities across 9 years of filings, most recently posting $770000.0 for Q1 2022.

• Other Non-Current Liabilities for Q1 2022 came in at $770000.0, up 1440.0% year-over-year; the trailing twelve-month figure through Mar 2022 was $770000.0 (up 1440.0% YoY), and the FY2021 annual result was $1.3 million, up 2424.0% from the prior year.
• Other Non-Current Liabilities came in at $770000.0 for Q1 2022 at vTv Therapeutics, down from $1.3 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $1.3 million in Q4 2021 to a low of $50000.0 in Q4 2020.
• The 5-year median for Other Non-Current Liabilities is $258000.0 (2018), against an average of $276294.1.
• Across the five-year window, Other Non-Current Liabilities slumped 80.77% in 2020 and jumped 2424.0% in 2021, its largest moves.
• vTv Therapeutics' Other Non-Current Liabilities stood at $260000.0 in 2018, then changed by 0.0% to $260000.0 in 2019, then plunged by 80.77% to $50000.0 in 2020, then surged by 2424.0% to $1.3 million in 2021, then tumbled by 38.99% to $770000.0 in 2022.
• The last three Other Non-Current Liabilities figures came in at $770000.0 (Q1 2022), $1.3 million (Q4 2021), and $50000.0 (Q3 2021), per Business Quant data.